The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer
Support Line: 0300 373 8500

Oxford Pre-cancerous Lymphoproliferative Disorders Study (OxPLoreD)

Looking for markers that might predict disease is progressing
Main Aims

This is a type of study known as ‘observational’ where researchers follow groups of patients but there is no treatment given as a part of the trial.
Participants in the trial will still have their usual appointments and therapies with their healthcare team, but their experiences help researchers look for trends that help them understand the disease better.
This study is looking for evidence that might help clinicians predict when someone’s disease is getting worse. This study is on-going but currently closed to recruitment.

Recruitment Criteria

• Confirmed diagnosis of WM but asymptomatic

• Or confirmed diagnosis of IgM Monoclonal Gammopathy of Uncertain Significance (MGUS)

Recruitment status: Not Recruiting
Sponsor: University of Oxford
Expected to end: 01/10/2025
Phases: